| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/07/1998 | CA2269670A1 A method for lowering plasma levels of lipoprotein(a) |
| 05/07/1998 | CA2269660A1 Combination therapy for the treatment of diabetes and obesity |
| 05/06/1998 | EP0839191A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 05/06/1998 | EP0839132A1 Novel process for the production of amorphous [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 05/06/1998 | EP0839039A1 Paroxetine controlled release compositions |
| 05/06/1998 | EP0730577B1 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds |
| 05/06/1998 | CN1181079A Novel triazolones as apolipoprotein-B synthesis inhibitors |
| 05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
| 05/06/1998 | CN1181060A Alk(En)yl dicarboxylic acid bisesters, their use and method for preparing them |
| 05/06/1998 | CN1181012A Method of lessening the rish of non-vertebral bone fractures |
| 05/06/1998 | CN1180541A 珍芪降糖胶囊及其生产工艺 Zhen Qi Hypoglycemic Capsules and its production process |
| 05/05/1998 | US5747642 Monomeric insulin analog formulations |
| 05/05/1998 | US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
| 05/05/1998 | US5747539 Fluorine-containing benzoylguanidines |
| 05/05/1998 | US5747510 Pharmaceutical unit dosage formulations |
| 05/05/1998 | US5747509 Prevention of occlusion in arteries |
| 05/05/1998 | US5747505 Heterocyclic aryl-, alkyl- and cycloalkylacetamides |
| 05/05/1998 | US5747501 Indole derivatives |
| 05/05/1998 | US5747481 Analgesics and antiinflammaory agents |
| 05/05/1998 | US5747478 Vitamin D3 analogs for the treatment of psoriasis and sebaceous gland diseases |
| 05/05/1998 | US5747456 Continuous low-dose administration of parathyroid hormone or its agonist |
| 05/05/1998 | US5747451 Diagnosis and prevention of arteriosclerosis |
| 05/05/1998 | US5747325 Artificial cells for treatment of diabetes to form insulin |
| 05/05/1998 | US5747295 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T |
| 05/05/1998 | US5747290 Process for the production of recombinant polypeptides |
| 04/30/1998 | WO1998017707A1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption |
| 04/30/1998 | WO1998017690A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | WO1998017671A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 04/30/1998 | WO1998017659A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 04/30/1998 | CA2269656A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | CA2269586A1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption |
| 04/30/1998 | CA2268876A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 04/30/1998 | CA2240458A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 04/29/1998 | EP0838473A1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient |
| 04/29/1998 | EP0838464A1 Substituted benzo(b)thiophene compounds having activity as selective estrogen receptor modulators |
| 04/29/1998 | EP0838462A1 Benzothiophene compounds, intermediates, compositions, and methods |
| 04/29/1998 | EP0838461A2 Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity |
| 04/29/1998 | EP0838459A1 Naphthyl compounds, compositions, and methods |
| 04/29/1998 | EP0837938A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837854A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 04/29/1998 | EP0837681A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 04/29/1998 | EP0837672A1 Preparations and methods for the treatment of t cell mediated diseases |
| 04/29/1998 | EP0734373B1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them |
| 04/29/1998 | EP0720597B1 Triaryl-ethylene derivatives for use in therapy |
| 04/29/1998 | EP0536269B1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/29/1998 | CN1180358A Bridged indoles as matrix metalloprotease inhibitors |
| 04/29/1998 | CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 04/29/1998 | CN1179963A Method for preparing animal and plant full natural nutrient solution and its product |
| 04/28/1998 | US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 04/28/1998 | US5744483 Neuroprotective compounds |
| 04/28/1998 | US5744477 Administering an inhibitor in combination with restricting the caloric intake of the subject |
| 04/28/1998 | US5744471 Pyridazion quinoline compounds |
| 04/28/1998 | US5744467 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 04/28/1998 | US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
| 04/28/1998 | US5744327 Methods for producing insulin in response to non-glucose secretagogues |
| 04/28/1998 | US5744161 Gastrointestinal absorption |
| 04/25/1998 | CA2218756A1 Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators |
| 04/24/1998 | CA2215647A1 Naphthyl compounds, compositions, and methods |
| 04/23/1998 | WO1998016543A1 Remedy for chronic fatigue syndrome |
| 04/23/1998 | WO1998016243A1 Uses of keratinocyte growth factor-2 |
| 04/23/1998 | WO1998016239A1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 04/23/1998 | WO1998016237A1 Anion exchange resin-containing tablets |
| 04/23/1998 | WO1998016221A1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 04/23/1998 | WO1998016220A1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1997046585A3 Fragments of leptin (ob protein) |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | CA2240402A1 Anion exchange resin-containing tablets |
| 04/22/1998 | EP0837072A2 Lys (B28) insulins. Human insulin analogues |
| 04/22/1998 | EP0837069A1 Storage-stabilization method of acarbose |
| 04/22/1998 | EP0837055A1 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them |
| 04/22/1998 | EP0836642A1 Conversion of compactin to pravastatin by actinomadura |
| 04/22/1998 | EP0836620A1 Anti-obesity proteins |
| 04/22/1998 | EP0836606A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 04/22/1998 | EP0836479A2 Methods for treating diabetes |
| 04/22/1998 | EP0836445A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/22/1998 | EP0708755B1 Novel vitamin d analogues |
| 04/22/1998 | EP0661933B1 Morphogen-enriched dietary composition |
| 04/22/1998 | EP0644891B1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 04/22/1998 | EP0631500B1 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4 |
| 04/22/1998 | EP0618906B1 Substituted imidazole derivatives and their preparation and use |
| 04/22/1998 | EP0607245B1 Cholesterol lowering compounds and process for making them |
| 04/22/1998 | EP0515460B1 Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1038131C Pyrrolopyrimidines and its preparing intermediate and medicinal composition containing same and use |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741791 Administering compounds which inhibit secretion, circulation or effect of insulin antagonizing peptides; can be used to treat non-insulin-dependent diabetes mellitus |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |
| 04/21/1998 | US5741785 Imidazolo(1,2-a)quinoxalinone compounds; antiischemic agents; nervous system disorders |
| 04/21/1998 | US5741776 Method of administration of IGF-I |
| 04/21/1998 | US5741673 Nucleic acid encoding a novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 04/21/1998 | US5741503 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/21/1998 | US5741491 Medicinal composition for diabetes |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015550A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015549A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015548A1 1,4-disubstituted piperazines |
| 04/16/1998 | WO1998015546A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015281A1 Induction of a cellular stress response with heavy metal salts |